In addition, immunoblot analysis revealed significantly higher conversion levels of LC3-I to LC3-II and a higher level of Atg5 expression in the osteosarcoma cells that had been treated with 0.2 μg/ml Dox or 20 μM Cis (Fig. 1C–E). This evidence concerns the gene ATG5 and osteosarcoma.